These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9206600)

  • 1. [Cerebral palsy therapy].
    Papazian O; Alfonso I
    Rev Neurol; 1997 May; 25(141):728-39. PubMed ID: 9206600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic interventions for tone abnormalities in cerebral palsy.
    Tilton AH
    NeuroRx; 2006 Apr; 3(2):217-24. PubMed ID: 16554259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Management of spasticity in children with cerebral palsy].
    Matthews DJ; Balaban B
    Acta Orthop Traumatol Turc; 2009; 43(2):81-6. PubMed ID: 19448346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Botulinum toxin type A in the treatment plan for cerebral palsy].
    Strobl W
    Wien Klin Wochenschr; 2001; 113 Suppl 4():30-5. PubMed ID: 15506050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of spasticity in children with cerebral palsy.
    Tilton A
    Semin Pediatr Neurol; 2009 Jun; 16(2):82-9. PubMed ID: 19501336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of spasticity].
    Autti-Rämö I
    Duodecim; 1999; 115(8):877-85. PubMed ID: 11859520
    [No Abstract]   [Full Text] [Related]  

  • 7. Intrathecal baclofen.
    Russman BS
    Dev Med Child Neurol; 2010 Jul; 52(7):601-2. PubMed ID: 19832881
    [No Abstract]   [Full Text] [Related]  

  • 8. New approaches to managing spasticity in children with cerebral palsy.
    Im D; McDonald CM
    West J Med; 1997 Apr; 166(4):271. PubMed ID: 9168686
    [No Abstract]   [Full Text] [Related]  

  • 9. Botulinum toxin type A with oral baclofen versus oral tizanidine: a nonrandomized pilot comparison in patients with cerebral palsy and spastic equinus foot deformity.
    Dai AI; Wasay M; Awan S
    J Child Neurol; 2008 Dec; 23(12):1464-6. PubMed ID: 19073853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrathecal baclofen infusion for ambulant children with cerebral palsy.
    Brochard S; Remy-Neris O; Filipetti P; Bussel B
    Pediatr Neurol; 2009 Apr; 40(4):265-70. PubMed ID: 19302938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Spasticity management and progress in ambulatory cerebral palsy].
    Filipetti P; Caldas C; Delpierre Y
    Arch Pediatr; 2006 Jun; 13(6):614-5. PubMed ID: 16697586
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy of intrathecal baclofen therapy in children with intractable spastic cerebral palsy: a randomised controlled trial.
    Hoving MA; van Raak EP; Spincemaille GH; Palmans LJ; Becher JG; Vles JS;
    Eur J Paediatr Neurol; 2009 May; 13(3):240-6. PubMed ID: 18595749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrathecal baclofen in the management of spasticity due to cerebral palsy.
    Vloeberghs M; Keetley R; Morton R
    Pediatr Rehabil; 2005; 8(3):172-9. PubMed ID: 16087551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrathecal baclofen use in adults with cerebral palsy.
    Krach LE
    Dev Med Child Neurol; 2009 Oct; 51 Suppl 4():106-12. PubMed ID: 19740217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epilepsy and intrathecal baclofen therapy in children with cerebral palsy.
    Buonaguro V; Scelsa B; Curci D; Monforte S; Iuorno T; Motta F
    Pediatr Neurol; 2005 Aug; 33(2):110-3. PubMed ID: 16087055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness modeling of intrathecal baclofen therapy versus other interventions for disabling spasticity.
    Bensmail D; Ward AB; Wissel J; Motta F; Saltuari L; Lissens J; Cros S; Beresniak A
    Neurorehabil Neural Repair; 2009; 23(6):546-52. PubMed ID: 19228818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of continuous intrathecal baclofen infusion in non-ambulant children with cerebral palsy.
    Miller F
    Dev Med Child Neurol; 2011 Aug; 53(8):679-80. PubMed ID: 21707603
    [No Abstract]   [Full Text] [Related]  

  • 18. Selective posterior rhizotomy and intrathecal baclofen for the treatment of spasticity.
    Mooney JF
    Pediatr Neurosurg; 2002 Apr; 36(4):223. PubMed ID: 12006760
    [No Abstract]   [Full Text] [Related]  

  • 19. Editorial. Is percutaneous thermal radiofrequency rhizotomy a viable alternative to selective dorsal rhizotomy or intrathecal baclofen for nonambulatory children with severe spasticity from cerebral palsy?
    Burchiel K
    Neurosurg Focus; 2024 Jun; 56(6):E8. PubMed ID: 38823053
    [No Abstract]   [Full Text] [Related]  

  • 20. Continuously infused intrathecal baclofen over 12 months for spastic hypertonia in adolescents and adults with cerebral palsy.
    Meythaler JM; Guin-Renfroe S; Law C; Grabb P; Hadley MN
    Arch Phys Med Rehabil; 2001 Feb; 82(2):155-61. PubMed ID: 11239304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.